Pharmacotherapy of Non-malignant pain
Erik Trimarelli, PharmD Candidate 2007
Epidemiology /- Pain affects millions of people every year
- Nearly ½ of the population has received some sort of pain intervention
- About 1/3 of the population suffered from chronic pain and resulted in 700,000,000 work days lost
- The annual direct and indirect costs of pain in American society is approaching $100,000,000,000
DiseaseState Definition /
- Pain is an integral element of trauma, surgery, and many other medical procedures
- Pain is a conscious event that is experienced when pain signals are successfully transmitted to the
injury/disease → noxious stimulus → nociceptive impulses → stimulus reaches consciousness
- Pain can be classified as acute, chronic (not associated with malignancy), and malignant pain
Patho-physiology /
- Nocioception has 4 major components
transmission- the conduction of noxious impulses from site of injury toward the spinal cord
perception- the movement of nociceptive information from the spinal cord to the cerebral cortex
modulation- activation of non-nociceptive sensations which reduce the sensation of pain
- Nociceptors are peripheral afferent neurons that have a very thin or non-existent myelin sheath
-types include A-delta and C fibers
- Transduction and transmission involve many different substances/ligands
-inhibatory: opioids, endocannabinoids, GABA, acetylcholine
Clinical Presentation / somatic / visceral / neuropathic
location / localized / generalized / radiating
clinical features / stabbing or sharp / deep pressure/ aching / burning/tingling
examples / superficial burns/lacerations / muscle spasm, kidney stone / diabetic/HIV neuropathy
Diagnosis /
- There are no diagnostic tests for pain, however X-ray, PET, and CT scanning all play a role in
- Assessment is key in treatment/monitoring patient progress
- Many different scales used to assess patient pain
-verbal scales
-numerical scales
Treatment Options**
(Non-drug and Drug Therapy – include all therapeutic classes/agents available and preferences per treatment guidelines)
**See Treatment Options Table / see treatment options table
Monitoring
(Efficacy and Toxicity Parameters) /
- pain assessment score
- functional status
- behavior status
- adverse effects (see treatment options table)
References
1. Institute for Clinical Systems Improvement (ICSI). Assessment and management of acute pain.
Bloomington (MN): ICSI; March 2006.
2. Institute for Clinical Systems Improvement (ICSI). Assessment and management of chronic pain.
Bloomington (MN): ICSI; November 2005.
3. Lipman AG. Pain Management for Primary Care Clinicians. Bethesda (MD): American Society of Health
System Pharmacists; 2004.
4. Baumann TJ. Pain management. In: DiPiro JT et al. (eds). Pharmacotherapy: A Pathophysiologic
Approach, 6th edition, 2005, pp 1089-1104.
5. Reisner L, Koo PJ. Pain and its management. In Koda-Kimble MA, et al. (eds). Applied Therapeutics: The
Clinical Use of Drugs, 8th edition, 2005, pp.9.1-9.40.